Perspective Therapeutics (CATX) Interest Coverage Ratio (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.72% |
| Dec 31, 2025 | -45.20% |
| Sep 30, 2025 | -112.18% |
| Jun 30, 2025 | -18.44% |
| Mar 31, 2025 | -127.68% |
| Dec 31, 2024 | 328.18% |
| Sep 30, 2024 | 56.45% |
| Jun 30, 2024 | -38.28% |
| Mar 31, 2024 | 7.82% |
| Dec 31, 2023 | 30.14% |
| Sep 30, 2023 | -85.64% |
| Jun 30, 2023 | 30.82% |
| Sep 30, 2015 | -261.26% |
| Jun 30, 2015 | 106.78% |
| Sep 30, 2014 | 98.57% |
| Dec 31, 2013 | -628.91% |
| Sep 30, 2013 | 99.84% |
| Sep 30, 2012 | -1,101,216.80% |
| Jun 30, 2012 | 92.73% |
| Mar 31, 2012 | 12.65% |
| Dec 31, 2011 | 97.72% |
| Sep 30, 2011 | -35,255.50% |
| Jun 30, 2011 | -735.50% |
| Mar 31, 2011 | 90.98% |
| Dec 31, 2010 | 77.37% |